• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Stille AB (publ) today presents the report for the first quarter 2026.

STILRegulatory press release2026-04-24 08:00
Download the release

Net sales amounted to MSEK 179.1 (129.3), which corresponds to an organic growth of 18.6 percent (26.9 percent in constant currencies) and a total growth of 38.5 percent (46.9 percent in constant currencies).

” I am very pleased with the start to 2026 and our strong growth in both revenue and profitability, says Ulrik Berthelsen. We continue to see strong demand for our products while at the same time improving product availability.”

The gross margin was 49.1 percent (51.1) and EBITDA before non-recurring items amounted to MSEK 38.5 (25.2).

” With a strengthened Group structure and cash position, we are well positioned to continue building the Stille Group through selective acquisitions. We look forward to the rest of 2026 and further evolving the Stille Group”, the Stille CEO concludes.

MSEKJAN-MAR
2026
JAN-MAR
2025
APR-MAR
2025/2026
JAN-DEC
2025
Net sales179.1129.3617.4567.6
Gross profit, %49.151.148.750.7
EBITDA before non-recurring items38.525.2127.1113.8
EBITDA before non-recurring items, %21.519.520.620.0
EBITDA38.525.2120.0106.7
EBITDA, %21.519.519.418.8
EBIT before non-recurring items30.017.992.480.3
EBIT before non-recurring items, %16.713.815.014.2
EBIT30.017.985.373.2
EBIT, %16.713.813.812.9

This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-24 08:00 CEST.

Contact Details
Ulrik Berthelsen
CEO & President
+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se

About Us
Stille AB (publ) is a well-established pioneer in the development, manufacturing and distribution of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high-precision procedures. Stille was founded in 1841 and is listed on Nasdaq First North Growth Market under the ticker “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, +46 8 684 211 10, adviser@eminova.se. More information is available at www.stille.se.

Attachments
Interim Report Stille Q1 2026